Biomarkers have been an important addition to the toolbox of rheumatology healthcare providers, which was illustrated in my interactions with G.H., a recent patient of […]
Twelve years ago, I met R.T., a 35-year-old female patient who had previously been diagnosed with rheumatoid arthritis. Her rheumatoid factor was positive at 49. […]
Several years ago, I was involved in an early trial of adalimumab in pediatric patients with juvenile inflammatory arthritis (JIA). One precocious 12-year-old girl enrolled […]
Learning the science of rheumatology is, for me, an ongoing project. The immune cascade is amazing and yet daunting to comprehend. The exciting part is […]
Picture this: A 43-year-old nurse practitioner (that’s me) on the floor of her 8-year- old daughter’s Disaster Area bedroom, drawing different colored blobs with pointy […]
In rheumatology, we are challenged with the formidable task of simultaneously improving quality, enhancing equity, and ensuring value in the care we provide for our […]
In 2000, the Institute of Medicine (IOM) published its landmark report, To Er is Human: Building a Safer Health System, upon which the current trend […]